Adding to the growing body of evidence for how the protein
Cyclin-Dependent Kinase (CDK) - the 'master regulator' of cell
division - operates, researchers at the Francis Crick Institute
propose a new explanation for the timing of its action.
Frank Uhlmann of the Crick explains the background to the work:
"The cell division cycle is a series of events by which a cell
grows and duplicates all its content, before dividing in two. This
process is orchestrated by CDK.
"One of the big mysteries is how CDK gets the timing right -
first the cellular content, especially chromosomes, must be
duplicated and only afterwards must the cell divide."
CDK regulates proteins involved in the cell cycle by chemically
adding a phosphate group to them. This process is called
phosphorylation and it works like a switch to turn on the protein
which is being modified.
Dr Uhlmann adds: "The question is, how does CDK know which
proteins to phosphorylate first?"
The researchers used budding yeast cells in their experiments.
The principles of cell cycle regulation are the same in yeast and
humans, but yeast is much simpler and easier to manipulate. Molly
Godfrey in Dr Uhlmann's lab worked with Andrew Jones and Bram
Snijders from the Crick's Mass Spectrometry Proteomics Science
Technology Platform, who carried out phospho-proteome analysis.
This takes stock of all the phosphorylated proteins inside a yeast
cell.
The team investigated enzymes called phosphatases that undo
phosphorylation by removing the phosphate group. They found one
(called PP2ACdc55) that counteracts CDK's
phosphorylation on a subset of its targets, thereby helping to
explain the timing of CDK action.
Proteins that escape this phosphatase get phosphorylated early
in the cell division cycle, while proteins that experience
dephosphorylation by the phosphatase have to wait until higher
levels of CDK activity accumulate before phosphorylation wins over
dephosphorylation.
The researchers also discovered how this phosphatase selects the
proteins for which it delays phosphorylation. It was already known
that CDK adds phosphates to either serine or threonine amino acids
on the surface of proteins. These two amino acids are very similar
and until now it was thought that there was no difference between
serine and threonine phosphorylation.
But the researchers found that the phosphatase
PP2ACdc55 counteracts threonine, but not serine,
phosphorylation. Thus threonine-phosphorylated proteins are
phosphorylated later.
Dr Uhlmann says: "A multitude of biological processes are
regulated by phosphorylation, including, among other things,
immunity and growth factor signalling. Our realisation that
phosphorylation timing depends on the amino acid that accepts the
phosphate group will almost certainly be applicable to the
regulation of many other events."
This research complements recent work led by Matthew Swaffer in Sir Paul
Nurse's lab at the Crick. Dr Swaffer's paper in Cell provides
convincing evidence for the 'activity threshold model' for CDK.
This model proposes that CDK controls cell division simply by
turning on the proteins needed at different stages of the process
based on increases in its own activity level.
Dr Uhlmann says: "These pieces of work show that if we look at
protein phosphorylation during the cell cycle, we should always
consider both directions: putting the phosphate on (Matthew
Swaffer's work) and taking it off again (our paper). Both processes
happen at the same time and it's the relative strengths of both
reactions that decide on the ultimate outcome of whether a protein
is phosphorylated or not."
Dr Uhlmann's paper, PP2ACdc55 phosphatase imposes ordered
cell cycle phosphorylation by opposing threonine
phosphorylation, is published in Molecular Cell.